GentiBio

0 followers


GentiBio, Inc., is an early stage biotherapeutics company co-founded by pioneers in Treg biology and synthetic immunology to develop engineered regulatory T cells (EngTregs) programmed to treat autoimmune, alloimmune, autoinflammatory and allergic diseases. GentiBio's proprietary autologous and allo... Read more

Employees

51-200

Links


Org chart

Tom Wickham
Chief Scientific Officer
Nishat Shaikh
VP, Intellectual Property & Contracts
Tiffany Chen
VP, Discovery
Margaret Readio
Director & Head, Technical Development Operations
Adan Jaramillo
Senior Director, Quality
Tom Crevier
Senior Director, Automation, Informatics, & IT
John Wesner
Director, Process Development
Marko Repic
Director, Pharmacology & Toxicology
Alberto del Rio Espinola
Director, Translational Sciences
Christopher L. Moore
Director, Discovery
Rachel Yost
Associate Director, MSAT
Jennifer Hu
Associate Director, Vector Analytics
Alexa Perdikis
Associate Director, Talent Acquisition & Employee Experience
Jaii Fredregill
Executive Assistant
Abby Meiners
Associate Scientist I
Tim Guo (Tingxi)
Principal Scientist
Hatem Heikal
VP, Finance
Emily Doll
Director, Controller
Hatem H.
Vice President Finance

Board & advisors

David Rawlings
Scientific Co-founder & Senior Scientific Advisor
Abhiram Rao
Director
Andy Tran
Board Director And Lead Investor
Jane Buckner
Scientific Advisor
Gideon Gross
Scientific Advisor
Amy Jennings
Scientific Advisor
Stanford Peng
Scientific Advisor
Andrew M. Scharenberg
Scientific Advisor
Hadas Weinstein-Marom
Scientific Advisor
Adam Cotton
Board Member